Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Cathay Biotech Inc.
  6. Summary
    688065   CNE100004447

CATHAY BIOTECH INC.

(688065)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
11/30/2021 12/01/2021 12/02/2021 12/03/2021 12/06/2021 Date
163 165.65 162 158.35 159.4 Last
1856495 1020074 1034753 928278 1080717 Volume
+4.65% +1.63% -2.20% -2.25% +0.66% Change
Estimated financial data (e)
Sales 2019 1 916 M 301 M 301 M
Net income 2019 479 M 75,1 M 75,1 M
Net cash position 2019 925 M 145 M 145 M
P/E ratio 2019 -
Yield 2019 -
Sales 2020 1 497 M 235 M 235 M
Net income 2020 458 M 71,8 M 71,8 M
Net cash position 2020 7 040 M 1 104 M 1 104 M
P/E ratio 2020 72,1x
Yield 2020 0,94%
Capitalization 66 419 M 10 417 M 10 418 M
EV / Sales 2019 -
EV / Sales 2020 19,0x
Nbr of Employees 1 308
Free-Float 19,8%
More Financials
Company
Cathay Biotech Inc is a company engaged in research, development, production and sales of biobased materials. The Company's primary products are biological long-chain dibasic acids, including lauric acid and brazilian acid, which are used in long-chain polyamides, fragrances, hot melt adhesives, lubricants, powder coatings and other areas. The Company sells its products to both domestic and international markets,... 
Sector
Specialty Chemicals
Calendar
03/29Earnings Release
More about the company
All news about CATHAY BIOTECH INC.
10/28Cathay Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 20..
CI
10/04HBM HEALTHCARE INVESTMENTS : Expects Decline In Fiscal H1 Profit
MT
08/18Cathay Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
08/12CATHAY BIOTECH INC.(SHSE : 688065) added to Shanghai Stock Exchange A Share Index
CI
08/12CATHAY BIOTECH INC.(SHSE : 688065) added to Shanghai Stock Exchange Composite Index
CI
04/26Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
03/29Cathay Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
2020Cathay Biotech Inc. Reports Earnings Results for the Nine Months of 2020
CI
2020Cathay Biotech Inc. has completed an IPO in the amount of CNY 5.560621 billion.
CI
2019Cathay Biotech Inc. has filed an IPO.
CI
More news
News in other languages on CATHAY BIOTECH INC.
10/22HBM Healthcare accuse un recul de plus d'un tiers de son bénéfice net
10/22HBM im Halbjahr 2021/22 nach starkem Vorjahr mit Gewinneinbruch
10/04HBM Healthcare s'attend à une baisse de son bénéfice pour le premier semestre fiscal
10/01Fort repli du bénéfice net semestriel pour HBM Healthcare
10/01HBM erwartet Semestergewinn von rund 270 Millionen Franken
More news
Chart CATHAY BIOTECH INC.
Duration : Period :
Cathay Biotech Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CATHAY BIOTECH INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 159,40 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Xiu Cai Liu Chairman & Chief Executive Officer
Joachim Friedrich Rudolf Chief Financial Officer & Director
Guo hua Zhang Chairman-Supervisory Board
Wan Zhong Chen Chief Engineer
Chu Sheng Chen Independent Director
Sector and Competitors